The field of the present disclosure generally relates to prosthetic devices for repairing and/or replacing native heart valves. More particularly, the field of the invention relates to prosthetic mitral valves having ventricular anchors that contribute to a relatively small crimp profile and are better suited to withstand stresses and strains during delivery into a patient.
Prosthetic valves may be used to treat cardiac valvular disorders. Native heart valves, such as aortic, pulmonary, tricuspid, and mitral valves, serve critical functions in assuring a forward flow of an adequate supply of blood through the cardiovascular system. Heart valves can be rendered less effective by congenital malformations, inflammatory processes, infectious conditions, or diseases. Damage to the valves typically results in serious cardiovascular compromise or death. For many years the definitive treatment for heart valve disorders has been surgical repair or replacement of valves by way of open heart surgery. Such surgeries, however, are highly invasive and prone to many complications. As such, elderly and frail patients with defective heart valves often go untreated.
Transvascular techniques have been developed for introducing and implanting a prosthetic heart valve using a flexible catheter in a manner that is much less invasive than open heart surgery. For example, a prosthetic valve may be mounted in a crimped state on an end portion of a flexible catheter and advanced through a blood vessel of a patient until the valve reaches an implantation site of a defective native valve. The prosthetic valve may then be expanded to a functional size at the implantation site such as by inflating a balloon on which the valve is mounted.
Another technique for implanting a prosthetic aortic valve is a transapical approach where a small incision is made in the chest wall of the patient and the catheter is advanced through the apex (i.e., bottom tip) of the heart. Transapical techniques are disclosed in U.S. Patent Application Publication No. 2007/0112422, which is hereby incorporated by reference. As with the transvascular approach, the transapical approach may include a balloon catheter having a steering mechanism for delivering a balloon-expandable prosthetic heart valve through an introducer to a defective native valve. The balloon catheter may include a deflecting segment just proximal to the distal balloon to facilitate positioning of the prosthetic heart valve in a proper orientation within an aortic annulus.
The above techniques and others provide numerous options for high operative risk patients with aortic valve disease to avoid the consequences of open heart surgery and cardiopulmonary bypass. While devices and procedures for aortic valves exist, such catheter-based procedures are not necessarily applicable to the mitral valve due to distinct differences between aortic and mitral valves. For example, the mitral valve has a complex subvalvular apparatus, known as chordae tendineae, which are not present in the aortic valve and can complicate valve delivery and placement.
When the native mitral valve fails to function properly, a prosthetic valve replacement may help restore proper functionality. Compared to the aortic valve, however, which has a relatively round and firm annulus, the mitral valve annulus can be relatively less firm and more unstable. Consequently, it may not be possible to secure a prosthetic valve that is designed for the aortic valve within the native mitral valve annulus by relying solely on friction from the radial force of an outer surface of a prosthetic valve pressed against the native mitral annulus. Accordingly, it may be beneficial to add ventricular anchors to prosthetic mitral valves to help secure the prosthetic valve within the native mitral valve annulus.
However, the addition of ventricular anchors may result in a relatively large crimp profile, including as large as 40 F (i.e., French Gauge). Further, a connection area between the ventricular anchors and the prosthetic valve may experience a relatively high degree of strain during crimping which may give rise to damage to the prosthetic valve during delivery into a patient. A prosthetic mitral valve having ventricular anchors that do not result in an overly large crimp profile or do not increase the size of the crimp profile and comprising a connection area that is better suited to withstand stresses and strains during delivery into the patient.
The drawings refer to embodiments of the present disclosure in which:
While the present disclosure is subject to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and will herein be described in detail. The invention should be understood to not be limited to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present disclosure. It will be apparent, however, to one of ordinary skill in the art that the invention disclosed herein may be practiced without these specific details. In other instances, specific numeric references such as “first leaflet,” may be made. However, the specific numeric reference should not be interpreted as a literal sequential order but rather interpreted that the “first leaflet” is different from a “second leaflet.” Thus, the specific details set forth are merely exemplary. The specific details may be varied from and still be contemplated to be within the spirit and scope of the present disclosure. The term “coupled” is defined as meaning connected either directly to the component or indirectly to the component through another component. Further, as used herein, the terms “about,” “approximately,” or “substantially” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein.
Described herein are embodiments of prosthetic valves and components thereof that are primarily intended to be implanted at the mitral valve region of a human heart. The prosthetic valves may be used to help restore and/or replace the functionality of a defective native mitral valve. However, while the disclosure focuses primarily on mitral valves the concepts, anchors/paddles, etc. are not limited to mitral valves and may be used on prosthetic valves, stents, etc. for use in other regions of the heart or parts of the body.
The mitral valve 2 includes an annulus portion 8, which is an annular portion of the native valve tissue surrounding the mitral valve orifice, and a pair of cusps, or leaflets, 10, 12 extending downward from the annulus 8 into the left ventricle 6. The mitral valve annulus 8 can form various shapes, e.g., an oval, “D” shape, saddle shape, bean shape, or some other out-of-round cross-sectional shape having major and minor axes. The anterior leaflet 10 can be larger than the posterior leaflet 12, as shown schematically in
When operating properly, the anterior leaflet 10 and the posterior leaflet 12 function together as a one-way valve to allow blood to flow only from the left atrium 4 to the left ventricle 6. The left atrium 4 receives oxygenated blood from the pulmonary veins 32. When the muscles of the left atrium 4 contract and the left ventricle 6 dilates, the oxygenated blood that is collected in the left atrium 4 flows into the left ventricle 6. When the muscles of the left atrium 4 relax and the muscles of the left ventricle 6 contract, the increased blood pressure in the left ventricle urges the two leaflets together, thereby closing the one-way mitral valve so that blood cannot flow back to the left atrium and is instead expelled out of the left ventricle through the aortic valve 14.
To prevent the two leaflets 10, 12 from prolapsing under pressure and folding back through the mitral annulus 8 toward the left atrium 4, a plurality of fibrous cords called chordae tendineae 16 (generally referred to as “chordae” herein) tether the leaflets 10, 12 to papillary muscles in the left ventricle 6. Referring to
When the native mitral valve fails to function properly, a prosthetic valve replacement may help restore proper functionality. Compared to the aortic valve, however, which has a relatively round and firm annulus, the mitral valve annulus can be relatively less firm and less stable. Consequently, it may not be possible to secure a prosthetic valve that is designed primarily for the aortic valve within the native mitral valve annulus by relying solely on friction from the radial force of an outer surface of a prosthetic valve pressed against the native mitral annulus. Accordingly, anchors/paddles (e.g., ventricular anchors/paddles) may be added to or used with prosthetic mitral valves, where the anchors operate instead of, or in addition to, radial friction forces, so as to secure the prosthetic valve within the native mitral valve annulus, e.g., as shown in
In addition to providing an anchoring means for the prosthetic valve, the ventricular anchors can also remodel the left ventricle 6 to help treat an underlying cause of mitral regurgitation—left ventricle enlargement/dilation. The ventricular anchors can pull the native mitral valve leaflets 10, 12 closer together and toward the left atrium and, via the chordae 16, thereby pull the papillary muscles 22, 24 closer together, which can positively remodel the ventricle acutely and prevent the left ventricle from further enlarging. Thus, the ventricular anchors can also be referred to as tensioning members or reshaping members.
The frame 102 may be made of a wire mesh or another type of stent frame and may be radially collapsible and expandable between a radially expanded state and a radially compressed state so as to enable delivery and implantation at the mitral valve region of the heart, or within another native heart valve. The wire mesh or stent frame may include metal wires or struts arranged in a lattice pattern, such as a saw-tooth or zig-zag pattern shown in
Additional details regarding components and assembly of prosthetic valves, as well as techniques for mounting leaflets to the frame, are described, for example, in U.S. Patent Application Publication No. 2009/0276040 A1, U.S. patent application Ser. No. 12/393,010, and U.S. Pat. No. 8,449,599, entitled “Prosthetic Valve for Replacing Mitral Valve,” issued on May 28, 2013, the entirety of each of which is incorporated by reference herein.
As best shown in
When the frame 102 is in an expanded state, as shown in
The wire spiral paddles 164 may comprise any number of turns, and may comprise various pitches and/or arrangement of turns so as to control the pressure and force distribution applied to the native leaflets 10, 12. The wire spiral paddles 164 are configured to apply a relatively uniform distribution of force onto the leaflets 10, 12 so as to provide relatively better anchoring of the prosthetic valve 160 within the heart. As will be appreciated, a substantially uniform force distribution operates to reduce pressure concentrations applied to the leaflets 10, 12, and thus reduces a risk of native leaflet abrasions once the prosthetic valve 160 is implanted within the mitral valve region of the heart. Further, the substantially uniform force applied by the anchors (e.g., by wire spiral paddles 164) to the native leaflets 10, 12 generally reduces strain on the anchors, thereby reducing a risk of material fatigue arising with the prosthetic valve 160. The wire spiral anchors/paddles 164 (as well as the other anchors/paddles described herein) may be coated with a soft material or be wrapped or surrounded in a cloth pouch or other padding (e.g., to help protect the native mitral valve leaflets and possibly to provide added friction, for example, with a textured surface or high friction surface). For example, the entire spiral may be wrapped in a cloth pouch (e.g., a wide pouch that surrounds all portions of the spiral in the same area) or a cloth sleeve that runs along the length of the paddle (e.g., the cloth sleeve may be long and narrow and may itself spiral with each turn of the wire).
As mentioned above, the wire spiral paddles 164 significantly reduce the crimp profile of the frame 102.
As mentioned above, the wire spiral paddles 164 generally are comprised of a wire extending from the ventricular end 130 of the main body 122 and coiled into a helix. When the helix presses against the exterior of the main body 122, the helix can flatten into the wire spiral paddles shown in
After forming (e.g., by laser cutting), the wire spiral paddles 164 may be shaped into a desired shape/form, e.g., as inwardly-directed helixes or 3D spirals as shown in
When the portion of the prosthetic valve 168 below the interlaced anchoring mechanism 172 exits the delivery system capsule, the cuts allow the exposed portion of the frame to expand to a profile that is larger than the portion of the remaining with the delivery system capsule. This is a partially deployed configuration. As shown in
There may be a plurality of openings 2502 defined by the frame 102. When the prosthetic valve 176 is implanted in a native mitral valve, the native leaflets 10, 12 are located between the paddles 184 and the frame 102. In particular, the native leaflets 10, 12 are located between the paddles 184 and two or more of the plurality of openings 2502 of the main body 122. The prosthetic valve 176 may further comprise a skirt 188 disposed within each of the windows 180. The skirts 188 may be configured to keep the paddles 184 circumferentially aligned with the main body 122 of the prosthetic valve when placed into the compressed state. The skirt 188 may be comprised of a biocompatible cloth, Nitinol fiber net, PTFE, ePTFE, or other suitable material having a comparable flexibility and capable of being sutured to cover the windows 180, as shown in
As stated above, the prosthetic valve 176 has a relatively small profile when crimped into the compressed state suitable for residing within a delivery system capsule. When the paddles 184 exit the delivery system capsule, however, the windows 180 allow the paddles 184 to expand away from the main body 122, such that the native leaflets 10, 12 may be drawn in between the paddles 184 and the main body. Once the entirety of the prosthetic valve 176 exits the delivery system capsule and fully expands, the native leaflets 10, 12 are then anchored between the main body 122 and the paddles 184.
In some embodiments, portions of the frame members 192 may be pre-shaped to radially protrude outside the circumference of the main body 190, and the paddles 196 may be pre-shaped to protrude radially inside the main body 190. With the frame members 192 protruding oppositely to the paddles 196, the windows 200 may effectively operate as a locking mechanism capable of gripping the native leaflets 10, 12, as shown in
Moreover, the frame members 192 and the paddles 196 may be covered or coated (partially or fully) with a soft material or cloth layer 197 or other padding in order to limit or prevent any damage to the native leaflets 10, 12. As shown in
As best illustrated in
As further illustrated in
Once the ribbon 264 is placed onto the paddle arm 268, as shown in
In some embodiments, the ribbon may be comprised of a knitted or folded ribbon that may be opened during expanding of the shape memory wire 260.
In the embodiments of 38A-39B and other embodiments in which the anchor has a reduced or narrowed profile during delivery and a larger or broader profile once deployed, this type of configuration may be beneficial in positioning the anchors/paddles in regions including chordae. The reduced or narrowed profile may allow the anchor/paddle to avoid or pass through or around chordae more easily, whereas the larger or broader profile may allow for better anchoring and may help prevent the anchor/paddle from slipping past the chordae and out of position.
As will be appreciated, mitral prostheses with paddles that clamp over the native leaflets 10, 12 may require or may be beneficially provided with frame padding so as to avoid trauma to the leaflets. The padding may be thick to help prevent damage, but the thick padding may a significant amount (e.g., 2 mm to 4 mm or more) to the crimp profile of the prosthesis. As will be recognized, the thickest cross-section generally is around the paddles due to the presence of the frame, frame padding, paddle wire, and paddle padding. One approach to reducing the crimp profile of the prosthesis is to install the padding after delivering the prosthesis.
While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Further, features described according to one embodiment above may be combined with features of other embodiments described above, even if not expressly described together. To the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well. Therefore, the present disclosure is to be understood as not limited by the specific embodiments described herein, but only by scope of the appended claims.
This application claims the benefit of U.S. Provisional Application No. 62/253,475, filed Nov. 10, 2015, which is hereby incorporated in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3409013 | Berry | Nov 1968 | A |
3472230 | Fogarty | Oct 1969 | A |
3548417 | Kisher | Dec 1970 | A |
3587115 | Shiley | Jun 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4406022 | Roy | Sep 1983 | A |
4470157 | Love | Sep 1984 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4574803 | Storz | Mar 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Sammuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5108370 | Walinsky | Apr 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5192297 | Hull | Mar 1993 | A |
5232446 | Arney | Aug 1993 | A |
5266073 | Wall | Nov 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411055 | Kane | May 1995 | A |
5411522 | Trott | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5599305 | Hermann et al. | Feb 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5639274 | Fischell et al. | Jun 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5906619 | Olson et al. | May 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6042607 | Williamson, IV et al. | Mar 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174327 | Mertens et al. | Jan 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217585 | Houser et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6245040 | Inderbitzen et al. | Jun 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6287339 | Vazquez et al. | Sep 2001 | B1 |
6299637 | Shaolian | Oct 2001 | B1 |
6302906 | Goecoechea et al. | Oct 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6379372 | Dehdashtian et al. | Apr 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | Di Matteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468660 | Ogle | Oct 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6527979 | Constantz | Mar 2003 | B2 |
6540782 | Snyders | Apr 2003 | B1 |
6569196 | Vesely et al. | May 2003 | B1 |
6575959 | Sarge et al. | Jun 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6605112 | Moll | Aug 2003 | B1 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6790229 | Berreklouw | Sep 2004 | B1 |
6830584 | Seguin | Dec 2004 | B1 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7524330 | Berreklouw | Apr 2009 | B2 |
7530253 | Spenser et al. | May 2009 | B2 |
7579381 | Dove | Aug 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7621948 | Herrmann et al. | Nov 2009 | B2 |
7704222 | Wilk et al. | Apr 2010 | B2 |
7736327 | Wilk et al. | Jun 2010 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
7914575 | Guyenot et al. | Mar 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8007992 | Tian et al. | Aug 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8092521 | Figulla et al. | Jan 2012 | B2 |
8118866 | Herrmann et al. | Feb 2012 | B2 |
8167932 | Bourang | May 2012 | B2 |
8206437 | Bonhoeffer et al. | Jun 2012 | B2 |
8216174 | Wilk et al. | Jul 2012 | B2 |
8317858 | Straubinger et al. | Nov 2012 | B2 |
8398704 | Straubinger et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8416643 | Magee | Apr 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8460370 | Zakay | Jun 2013 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030100939 | Yodfat et al. | May 2003 | A1 |
20030158597 | Quiachon et al. | Aug 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040133263 | Dusbabek et al. | Jul 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137698 | Salahieh et al. | Jun 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050288766 | Plain et al. | Dec 2005 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060142837 | Haverkost et al. | Jun 2006 | A1 |
20060149350 | Patel et al. | Jul 2006 | A1 |
20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060276874 | Wilson et al. | Dec 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070027534 | Bergeim et al. | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070066863 | Rafiee et al. | Mar 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070100439 | Cangialosi et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070156224 | Cioanta et al. | Jul 2007 | A1 |
20070203503 | Salahieh et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070270943 | Solem | Nov 2007 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071368 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090054968 | Bonhoeffer et al. | Feb 2009 | A1 |
20090054974 | McGuckin, Jr. et al. | Feb 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090164005 | Dove et al. | Jun 2009 | A1 |
20090171432 | Von Segesser et al. | Jul 2009 | A1 |
20090171447 | Von Segesser et al. | Jul 2009 | A1 |
20090171456 | Kveen et al. | Jul 2009 | A1 |
20090216310 | Straubinger et al. | Aug 2009 | A1 |
20090216313 | Straubinger et al. | Aug 2009 | A1 |
20090216322 | Le et al. | Aug 2009 | A1 |
20090222076 | Figulla et al. | Sep 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100016958 | St. Goar et al. | Jan 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100069852 | Kelley | Mar 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100137979 | Tuval et al. | Jun 2010 | A1 |
20100168839 | Braido | Jul 2010 | A1 |
20100174362 | Straubinger et al. | Jul 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100262231 | Tuval et al. | Oct 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20110015616 | Straubinger et al. | Jan 2011 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110178597 | Navia et al. | Jul 2011 | A9 |
20110208290 | Straubinger et al. | Aug 2011 | A1 |
20110208297 | Tuval et al. | Aug 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110238159 | Guyenot et al. | Sep 2011 | A1 |
20110264198 | Murray, III et al. | Oct 2011 | A1 |
20110288634 | Tuval et al. | Nov 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120035722 | Tuval | Feb 2012 | A1 |
20120046741 | Tuval et al. | Feb 2012 | A1 |
20120046742 | Tuval et al. | Feb 2012 | A1 |
20120101570 | Tuval et al. | Apr 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120185039 | Tuval et al. | Jul 2012 | A1 |
20120197386 | Von Segesser et al. | Aug 2012 | A1 |
20120209374 | Bonhoeffer et al. | Aug 2012 | A1 |
20120283823 | Bonhoeffer et al. | Nov 2012 | A1 |
20120296418 | Bonyuet et al. | Nov 2012 | A1 |
20120310336 | Figulla et al. | Dec 2012 | A1 |
20130073035 | Tuval et al. | Mar 2013 | A1 |
20130079869 | Straubinger et al. | Mar 2013 | A1 |
20130190862 | Pintor et al. | Jul 2013 | A1 |
20130197622 | Mitra et al. | Aug 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20140046433 | Kovalsky | Feb 2014 | A1 |
20150127100 | Braido | May 2015 | A1 |
Number | Date | Country |
---|---|---|
102639179 | Aug 2012 | CN |
104220027 | Dec 2014 | CN |
2246526 | Mar 1973 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10010074 | Oct 2001 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049814 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
102006052564 | Dec 2007 | DE |
0103546 | Mar 1984 | EP |
0144167 | Jun 1985 | EP |
0592410 | Apr 1994 | EP |
0597967 | May 1994 | EP |
0850607 | Jul 1998 | EP |
1057460 | Dec 2000 | EP |
1088529 | Apr 2001 | EP |
1469797 | Oct 2004 | EP |
1570809 | Sep 2005 | EP |
1653888 | May 2006 | EP |
1849440 | Oct 2007 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2056023 | Mar 1981 | GB |
1271508 | Nov 1986 | SU |
9117720 | Nov 1991 | WO |
9217118 | Oct 1992 | WO |
93001768 | Feb 1993 | WO |
9724080 | Jul 1997 | WO |
9829057 | Jul 1998 | WO |
9933414 | Jul 1999 | WO |
9940964 | Aug 1999 | WO |
9947075 | Sep 1999 | WO |
0018333 | Apr 2000 | WO |
0041652 | Jul 2000 | WO |
0047139 | Aug 2000 | WO |
0128459 | Apr 2001 | WO |
0135878 | May 2001 | WO |
0149213 | Jul 2001 | WO |
0154624 | Aug 2001 | WO |
0154625 | Aug 2001 | WO |
0162189 | Aug 2001 | WO |
0164137 | Sep 2001 | WO |
0176510 | Oct 2001 | WO |
0222054 | Mar 2002 | WO |
0236048 | May 2002 | WO |
0241789 | May 2002 | WO |
0243620 | Jun 2002 | WO |
0247575 | Jun 2002 | WO |
0249540 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
05034812 | Apr 2005 | WO |
2005087140 | Sep 2005 | WO |
05102015 | Nov 2005 | WO |
2006014233 | Feb 2006 | WO |
2006034008 | Mar 2006 | WO |
06108090 | Oct 2006 | WO |
06111391 | Oct 2006 | WO |
2006138173 | Dec 2006 | WO |
2008005405 | Jan 2008 | WO |
2008035337 | Mar 2008 | WO |
2008147964 | Dec 2008 | WO |
2008150529 | Dec 2008 | WO |
09024859 | Feb 2009 | WO |
2009091509 | Jul 2009 | WO |
09116041 | Sep 2009 | WO |
2010121076 | Oct 2010 | WO |
2011081997 | Jul 2011 | WO |
2012095455 | Jul 2012 | WO |
2015125024 | Aug 2015 | WO |
2015188066 | Dec 2015 | WO |
Entry |
---|
Int'l. Search Report issued for PCT/US2016/061171, completed Feb. 20, 2017. |
Al-Khaja, N., et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery 3:305-311, Jun. 30, 2009. |
Almagor, M.D., Yaron, et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits,” Journal of the American College of Cardiology, vol. 16, No. 6, pp. 1310-1314, Nov. 1, 1990; ISSN 3735-1097. |
Al Zaibag, Muayed, et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenosis,” British Heart Journal, Jan. 1987, vol. 57, No. 1, pp. 51-53. |
Andersen, et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” European Heart Journal (1992), 13, 704-708. |
Andersen, Henning Rud, “History of Percutaneous Aortic Valve Prosthesis,” Herz 34 2009 Nr. 5, Urban & Vogel, pp. 343-346, Skejby University Hospital Department of Cardiology, Aarhus, Denmark. |
Benchimol, Alberto, et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man,” The American Journal of the Medical Sciences, Jan.-Feb. 1977 vol. 273, No. 1, pp. 55-62. |
Dake, Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms, New Engl.J.Med., 1994; 331:1729 34. |
Dotter, M.D., Charles T., “Transluminal Treatment of Arteriosclerotic Obstruction,” University of Oregon's Minthorn Memorial Laboratory for Cardiovascular Research through Radiology, Circulation, vol. XXX, Nov. 1964, pp. 654-670. |
Kolata, Gina, “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study,” nytimes.com, http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . , Jul. 29, 2009, 2 pages. |
Inoue, M.D., Kanji, et al., “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery 87:394-402, 1984. |
Lawrence, Jr., M.D., David D., “Percutaneous Endovascular Graft: Experimental Evaluation,” Radiology 1897; 163: 357-360. |
Pavcnik, M.D., Ph.D., Dusan, et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology 1992; 183:151-154. |
Porstmann, W., et al., “Der Verschluß des Ductus Arteriosus Persistens ohne Thorakotomie,” Thoraxchirurgie Vaskuläre Chirurgie, Band 15, Heft 2, Stuttgart, im Apr. 1967, pp. 199-203. |
Rashkind, M.D., William J., “Creation of an Atrial Septal Defect Withoput Thoracotomy,” the Journal of the American Medical Association, vol. 196, No. 11, Jun. 13, 1966, pp. 173-174. |
Rashkind, M.D., William J., “Historical Aspects of Interventional Cardiology: Past, Present, Future,” Texas Heart Institute Journal, Interventional Cardiology, pp. 363-367. |
Rösch, M.D., Josef, “The Birth, Early Years and Future of Interventional Radiology,” J Vasc Intery Radiol 2003; 14:841-853. |
Ross, F.R.C.S., D.N., “Aortic Valve Surgery,” Guy's Hospital, London, pp. 192-197, approximately 1968. |
Sabbah, Ph.D., Hani N., et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Journal of Cardiac Surgery, vol. 4, No. 4, pp. 302-309, Dec. 1989; ISSN 0886-0440. |
Selby, M.D., J. Bayne, “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems,” Radiology 1990; 176:535-538. |
Serruys, P.W., et al., “Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?,” European Heart Journal (1989) 10, 774-782, pp. 37-45, Jun. 13, 1989. |
Sigwart, Ulrich, “An Overview of Intravascular Stents: Old and New,” Chapter 48, Textbook of Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815. |
Uchida, Barry T., et al., “Modifications of Gianturco Expandable Wire Stents,” AJR:150, May 1988, Dec. 3, 1987, pp. 1185-1187. |
Urban, M.D., Philip, “Coronary Artery Stenting,” Editions Médecine et Hygiène, Genève, 1991, pp. 5-47. |
Watt, A.H., et al. “Intravenous Adenosine in the Treatment of Supraventricular Tachycardia; a Dose-Ranging Study and Interaction with Dipyridamole,” British Journal of Clinical Pharmacology (1986), 21, 227-230. |
Wheatley, M.D., David J., “Valve Prostheses,” Rob & Smith's Operative Surgery, Fourth Edition, pp. 415-424, Butterworths 1986. |
EP Search Report dated Jan. 28, 2016 for EP15181583. |
EP Search Report dated Feb. 23, 2016 for EP15197122. |
Number | Date | Country | |
---|---|---|---|
20170128199 A1 | May 2017 | US |
Number | Date | Country | |
---|---|---|---|
62253475 | Nov 2015 | US |